As of 2026-05-26, the EV/EBITDA ratio of Gufic Biosciences Ltd (GUFICBIO.NS) is 26.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GUFICBIO.NS's latest enterprise value is 35,407.32 mil INR. GUFICBIO.NS's TTM EBITDA according to its financial statements is 1,330.58 mil INR. Dividing these 2 quantities gives us the above GUFICBIO.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 14.0x | 10.0x |
| Forward P/E multiples | 8.8x - 10.7x | 9.1x |
| Fair Price | 79.71 - 262.63 | 161.58 |
| Upside | -75.5% - -19.2% | -50.3% |
| Date | EV/EBITDA |
| 2026-05-25 | 26.61 |
| 2026-05-22 | 24.14 |
| 2026-05-21 | 23.76 |
| 2026-05-20 | 23.67 |
| 2026-05-19 | 23.73 |
| 2026-05-18 | 23.10 |
| 2026-05-15 | 23.46 |
| 2026-05-14 | 23.67 |
| 2026-05-13 | 23.78 |
| 2026-05-12 | 25.10 |
| 2026-05-11 | 24.95 |
| 2026-05-08 | 25.10 |
| 2026-05-07 | 24.80 |
| 2026-05-06 | 24.24 |
| 2026-05-05 | 23.91 |
| 2026-05-04 | 24.27 |
| 2026-04-30 | 23.55 |
| 2026-04-29 | 23.82 |
| 2026-04-28 | 23.82 |
| 2026-04-27 | 24.29 |
| 2026-04-24 | 24.70 |
| 2026-04-23 | 24.43 |
| 2026-04-22 | 24.04 |
| 2026-04-21 | 23.97 |
| 2026-04-20 | 24.41 |
| 2026-04-17 | 24.80 |
| 2026-04-16 | 24.93 |
| 2026-04-15 | 25.32 |
| 2026-04-13 | 25.06 |
| 2026-04-10 | 24.79 |
| 2026-04-09 | 24.58 |
| 2026-04-08 | 24.57 |
| 2026-04-07 | 24.03 |
| 2026-04-06 | 24.42 |
| 2026-04-02 | 23.97 |
| 2026-04-01 | 23.59 |
| 2026-03-30 | 22.84 |
| 2026-03-27 | 23.22 |
| 2026-03-25 | 24.54 |
| 2026-03-24 | 23.16 |
| 2026-03-23 | 23.78 |
| 2026-03-20 | 24.36 |
| 2026-03-19 | 24.35 |
| 2026-03-18 | 24.94 |
| 2026-03-17 | 24.36 |
| 2026-03-16 | 23.59 |
| 2026-03-13 | 24.27 |
| 2026-03-12 | 23.89 |
| 2026-03-11 | 23.83 |
| 2026-03-10 | 23.61 |